Market cap
$11,355 Mln
Revenue (TTM)
$337,102 Mln
P/E Ratio
26.2
P/B Ratio
2.9
Div. Yield
0.6 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$39,751 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
13.8
-
Debt to Equity
0.2
-
Book Value
$442.7
-
EPS
$54
-
Face value
--
-
Shares outstanding
832,594,805
10 Years Aggregate
CFO
₹332,484.00 Mln
EBITDA
₹487,123.00 Mln
Net Profit
₹243,887.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Reddy's Laboratories - ADR
| -3.3 | -2.8 | -5.6 | -8.0 | 7.6 | -1.2 | 3.9 |
|
BSE Sensex*
| -10.4 | -1.0 | -7.8 | -7.7 | 6.7 | 8.3 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dr. Reddy's Laboratories - ADR
| -11.1 | 13.3 | 34.5 | -20.9 | -8.2 | 75.7 | 7.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Dr. Reddy's Laboratories - ADR
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active... Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Address: 8-2-337, Road No. 3, Hyderabad, India, 500034 Read more
-
Co-Chairman, MD & Member of Management Council
Mr. Gunupati Venkateswara Prasad B.E.
-
Co-Chairman, MD & Member of Management Council
Mr. Gunupati Venkateswara Prasad B.E.
-
Headquarters
Hyderabad
-
Website
FAQs for Dr. Reddy's Laboratories - ADR
What is the current share price of Dr Reddy's Laboratories Ltd - ADR Today?
The share price of Dr Reddy's Laboratories Ltd - ADR is $13.58 (NYSE) as of 28-May-2026 12:42 EDT. Dr Reddy's Laboratories Ltd - ADR has given a return of 7.59% in the last 3 years.
What is the current PB & PE ratio of Dr Reddy's Laboratories Ltd - ADR?
The P/E ratio of Dr Reddy's Laboratories Ltd - ADR is 26.15 times as on 22-May-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
0.26
|
0.03
|
|
2025
|
0.19
|
0.03
|
|
2024
|
1.10
|
0.22
|
|
2023
|
1.05
|
0.21
|
|
2022
|
1.97
|
0.24
|
What is the 52 Week High and Low of Dr Reddy's Laboratories Ltd - ADR?
The 52-week high and low of Dr Reddy's Laboratories Ltd - ADR are Rs 16.17 and Rs 12.19 as of 28-May-2026.
What is the market cap of Dr Reddy's Laboratories Ltd - ADR?
Dr Reddy's Laboratories Ltd - ADR has a market capitalisation of $ 11,355 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dr Reddy's Laboratories Ltd - ADR?
Before investing in Dr Reddy's Laboratories Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.